Skip to main content

Table 2 Patient outcome measures taken at baseline and 12 months

From: Improving outcomes among young adults with type 1 diabetes: the D1 Now pilot cluster randomised controlled trial

Construct to be measured

How was it measured?

Demographics

Self-report: gender, age, education status, occupation, duration of diabetes, co-morbidities, current insulin regimen, glucose monitoring method and other (non-insulin) medication.

Glycated haemoglobin (HbA1c)

Laboratory HbA1c within the last 3 months; if this was unavailable, the most recent point-of-care HbA1c result was used

Number of instances of diabetic ketoacidosis (DKA)

Medical record review and patient self-report; timeframe was over the past 12 months.

Number of instances of severe hypoglycaemia

Medical record review and patient self-report; timeframe was over the past 12 months.

Clinic engagement

This was operationalised as clinic attendance and was obtained from the clinic appointment administration system; timeframe was over the past 12 months.

Diabetes distress

Self-report: Measured using the Problems Areas in Diabetes-11 (PAID-11) scale [18].

Diabetes related quality of life

Self-report: Measured using the Audit of Diabetes Dependent Quality of life (ADDQOL) [19].

Diabetes related self-management

Self-report: Measured using the Diabetes Self-Management Questionnaire (DSMQ) [20]

Perceived level of control of diabetes

Self-report: Measured using the Diabetes Empowerment Scale-Short Form (DES-SF; 10) [21]